353 results on '"Lafay-Cousin, Lucie"'
Search Results
2. Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progress.
3. Cancer risk and tumour spectrum in 172 patients with a germline SUFU pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group.
4. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
5. Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort
6. Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort.
7. Marrow-ablative consolidation chemotherapy (HDCT) to decrease the development of choroid plexus carcinoma (CPC) specific relapse in high-risk TP53-mutated (germline or somatic) young children with newly diagnosed CPC.
8. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
9. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
10. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
11. Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas.
12. Treatment of Monomorphic Posttransplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant: A Multicenter Review
13. Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics
14. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC)
15. Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature
16. MEDULLOBLASTOMA
17. Treatment of Monomorphic Posttransplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant: A Multicenter Review.
18. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
19. Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes.
20. The Pediatric Toronto Extremity Salvage Score (pTESS): Validation of a Self-reported Functional Outcomes Tool for Children with Extremity Tumors
21. Atypical Teratoid Rhabdoid Tumors
22. Monomorphic Post-Transplant Lymphoproliferative Disorder in Pediatric Solid Organ Transplant Recipients: Treatment Approach Across Canada
23. Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy
24. Supplementary File 1 from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma
25. Supplementary File 2 from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma
26. Supplementary Methods and Data from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma
27. Data from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma
28. Supplementary File 3 from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma
29. Outcomes of Coronavirus Disease 2019 Infection in Children and Adolescents With Cancer in Canada: Population-based Study and Systematic Review
30. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
31. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study
32. CTNI-04. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS
33. Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
34. Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature
35. Cancer risk and tumour spectrum in 172 patients with a germlineSUFUpathogenic variation: a collaborative study of the SIOPE Host Genome Working Group
36. How do we approach the management of medulloblastoma in young children?
37. NFB-12. Effect of trametinib on leg length discrepancy in a child with NF1 related plexiform neurofibroma
38. RARE-19. Molecular characterization and treatment response of metastatic DIA/DIG
39. MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
40. NFB-08. TRAM-01: A Phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
41. Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive
42. Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortium
43. The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience
44. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis
45. Infant brain tumor trials: Beyond feasibility
46. Isolated Pulmonary Emergomycosis in an Immunocompetent Patient in Alberta, Canada
47. High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma
48. Incidence of medulloblastoma in Canadian children
49. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes
50. CTNI-06. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.